Respiratory Health: A Global Neglect Issue
News Context
At a glance
- Chronic respiratory diseases (MRCs) are a important,yet often overlooked,global health issue.
- The World Health Organization (WHO) is actively working to address these issues by:
- José Luis Castro,Special Envoy of WHO for MRCs,aims to bring these pathologies and patients "out of the shadows" and ensure they are included in all political agendas.
“`html
Chronic Respiratory Diseases: A global Health Challenge
Table of Contents
Chronic respiratory diseases (MRCs) are a important,yet often overlooked,global health issue. Thay represent a substantial avoidable burden, causing 4 million deaths annually, including nearly 400,000 in Europe.
Key Facts & Statistics
- Global Mortality: 4 million deaths per year.
- European Mortality: Nearly 400,000 deaths per year.
- Main Diseases: Asthma and Chronic Obstructive bronchopneumopathy (COPD).
- COPD Ranking: Was the 3rd leading cause of health-related deaths globally before the COVID-19 pandemic; currently 4th.
- Asthma Prevalence: Affects 250 million people worldwide.
- Projected MRC Prevalence: Expected to increase by 23% by 2050.
- Premature Deaths (Asthma): More than 1,000 premature deaths daily due to lack of access to therapies in low/intermediate income countries.
Challenges & Issues
- Underdiagnosis & Sub-financing: MRCs are frequently underdiagnosed and receive insufficient funding and policy support.
- Access to Diagnosis & Treatment: Difficulties in accessing diagnosis and treatment,notably in low and middle-income countries,are major concerns.
- Air Pollution: A significant contributing factor,including both indoor (biomass fuels) and outdoor (traffic,industry) pollution.
- COPD Misconceptions: The role of air pollution in COPD is often neglected, with smoking being the primary focus.
- Late Diagnosis of COPD: Gradual symptom onset leads to late diagnosis in approximately two-thirds of COPD patients.
Regional Focus: Europe & France
- Europe: MRC prevalence is projected to increase by 23% by 2050, disproportionately affecting women and disadvantaged populations. COPD accounts for 80% of MRC-related deaths.
- France: Between 3 and 3.5 million people are affected by COPD, but almost two-thirds remain undiagnosed and untreated.
WHO Initiatives
The World Health Organization (WHO) is actively working to address these issues by:
- Preparing recommendations on MRCs.
- Educating governments.
- Mobilizing funds.
José Luis Castro,Special Envoy of WHO for MRCs,aims to bring these pathologies and patients “out of the shadows” and ensure they are included in all political agendas.
Data Table: MRC impact (Illustrative)
| Region | Estimated Prevalence (Millions) | Annual Deaths | Projected Increase by 2050 |
|---|---|---|---|
| Global | ~650 | 4 | 23% |
| europe | ~80 | ~400,000 | 23% |
| France | 3 – 3.5 | Data not Available | Data Not Available |
Source: Based on data from